Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Goldberg

Showing results (31-40 of 358) with videos related to

Pageof 36
Sort By:
Clinical Colorectal Cancer|October 14, 2004
Combining anti-VEGF approaches with oxaliplatin in advanced colorectal cancerShannon K Penland, Richard M Goldberg
Nature Clinical Practice. Gastroenterology & Hepatology|May 2, 2007
Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?Bert H O'Neil, Richard M Goldberg
Gastrointestinal Cancer Research : GCR|March 6, 2009
Colorectal cancer treatment in older patientsHanna K Sanoff, Richard M Goldberg
Nature Clinical Practice. Oncology|November 13, 2008
What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?Bert H O'Neil, Richard M Goldberg
Seminars in Oncology|June 13, 2003
Optimal use of the combination of irinotecan and 5-fluorouracilAl B Benson, Richard M Goldberg
The New England Journal of Medicine|September 17, 2025
An Aspirin a Day for Improved Colorectal Cancer OutcomesRichard M Goldberg, Jeffrey A Meyerhardt
Seminars in Oncology|February 24, 2005
Chemotherapy for advanced colorectal cancer: let's not forget how we got here (until we really can)Bert H O'Neil, Richard M Goldberg
Hepatic Oncology|September 8, 2018
Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancerKristen K Ciombor, Richard M Goldberg
Oncology (Williston Park, N.Y.)|June 25, 2004
Current strategies in previously untreated advanced colorectal cancerShannon K Penland, Richard M Goldberg
The Oncologist|October 17, 2008
Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trialsBert H O'Neil, Richard M Goldberg
Pageof 36

Showing results (31-40 of 358) with videos related to

Sort By:
Pageof 36
Clinical Colorectal Cancer|October 14, 2004
Combining anti-VEGF approaches with oxaliplatin in advanced colorectal cancerShannon K Penland, Richard M Goldberg
Nature Clinical Practice. Gastroenterology & Hepatology|May 2, 2007
Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?Bert H O'Neil, Richard M Goldberg
Gastrointestinal Cancer Research : GCR|March 6, 2009
Colorectal cancer treatment in older patientsHanna K Sanoff, Richard M Goldberg
Nature Clinical Practice. Oncology|November 13, 2008
What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?Bert H O'Neil, Richard M Goldberg
Seminars in Oncology|June 13, 2003
Optimal use of the combination of irinotecan and 5-fluorouracilAl B Benson, Richard M Goldberg
The New England Journal of Medicine|September 17, 2025
An Aspirin a Day for Improved Colorectal Cancer OutcomesRichard M Goldberg, Jeffrey A Meyerhardt
Seminars in Oncology|February 24, 2005
Chemotherapy for advanced colorectal cancer: let's not forget how we got here (until we really can)Bert H O'Neil, Richard M Goldberg
Hepatic Oncology|September 8, 2018
Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancerKristen K Ciombor, Richard M Goldberg
Oncology (Williston Park, N.Y.)|June 25, 2004
Current strategies in previously untreated advanced colorectal cancerShannon K Penland, Richard M Goldberg
The Oncologist|October 17, 2008
Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trialsBert H O'Neil, Richard M Goldberg
Pageof 36